Financial Year |
March 31 2023 |
Monetary Funds |
133,076,188.02 |
Held-for-trading Financial Assets |
78,967,432.72 |
Notes Receivable |
-- |
Accounts Receivable |
32,038,249.98 |
Advances to Suppliers |
7,537,774.27 |
Other Receivables |
101,610.85 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
15,308,266.77 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
2,288,036.61 |
Total Current Assets |
271,154,888.70 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
6,905,099.14 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
34,963.74 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
1,014,819.70 |
Deferred Income Tax Assets |
42,623.97 |
Other Non-Current Assets |
259,250.00 |
Sub-Total of Non-Current Assets |
288,807,491.46 |
Total Assets |
559,962,380.16 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
94,500,000.00 |
Accounts Payable |
8,832,979.82 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
333,225.98 |
Taxes Payable |
158,656.15 |
Interest Payable |
-- |
Dividend Payable |
567,468.00 |
Other payables |
1,841,638.38 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
555,524.25 |
Other Current Liabilities |
171,228.40 |
Sub-Total of Current Liabilities |
107,710,394.55 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
57,922,351.78 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
59,004,180.04 |
Total Liabilities |
166,714,574.59 |
Paid-In Capital(Or Share Stock) |
133,747,200.00 |
Capital Surplus |
15,416,619.43 |
Surplus Reserve |
35,232,853.60 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
208,851,132.54 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
393,247,805.57 |
Owner's Equity(Stockholder's Equity) |
393,247,805.57 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
559,962,380.16 |